No injectables sale but Claris eyes US, EU expansion
This article was originally published in Scrip
Executive Summary
Arjun Handa, managing director and CEO of India's Claris Lifesciences, has ruled out any intent, at least for now, to divest the firm's specialty injectables business, but he did suggest that the company is keen to expand in the US and other markets.